World News | Oxford Vaccine Trial Continues Amid Death Report

London, Oct 22 (AP) The University of Oxford says the late-stage trial of its COVID-19 vaccine in Brazil will continue following reports of a participant's death.

The university said it can't comment on specific incidents but an independent review found no reason to be concerned about the safety of the Brazilian trial.

Also Read | Combined Vaccine Against COVID-19 and Flu Being Developed by Russian Research Centre; Key Updates on Anti-Coronavirus Vaccine Development in Russia.

It says an “independent review, in addition to the Brazilian regulator, have recommended that the trial should continue.”

The Oxford vaccine is being developed in conjunction with the international pharmaceutical company AstraZeneca. Trials are underway in the United States and the UK, as well as Brazil, to determine whether the potential vaccine is safe and effective in humans. (AP)

Also Read | Visa Restrictions Lifted: Indian Govt Restores All Visas, Except Electronic, Tourist and Medical Categories After 8 Months Amid COVID-19 Pandemic.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)